Methotrexate BAFFles anti-drug antibodies

被引：0
|
作者：
Bruce N. Cronstein
机构：
[1] New York University School of Medicine,
来源：
Nature Reviews Rheumatology | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Combining TNF inhibition with methotrexate treatment is an effective therapeutic approach for patients with rheumatoid arthritis and reduces the likelihood of the patient developing ‘resistance’ to the TNF inhibitor. But how does methotrexate suppress the production of anti-drug antibodies and how can we tell which patients will develop resistance?
引用
收藏
页码：505 / 506
页数：1
相关论文
共 50 条
  • [31] Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
    S. C. Sasson
    L. E. Wilkins
    R. A. Watson
    C. Jolly
    O. Brain
    P. Klenerman
    A. Olsson-Brown
    B. P. Fairfax
    Scientific Reports, 11
  • [32] Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
    Partridge, Michael A.
    Purushothama, Shobha
    Elango, Chinnasamy
    Lu, Yanmei
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [33] Factors that may influence the development of anti-drug antibodies to adalimumab
    Reinisch, W.
    Rauter, I.
    Chen, L.
    Gessner, M.
    Fanjiang, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S429 - S430
  • [34] Proactively Reducing Anti-Drug Antibodies via Immunomodulatory Bioconjugation
    Zhang, Peng
    Jain, Priyesh
    Tsao, Caroline
    Wu, Kan
    Jiang, Shaoyi
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (08) : 2433 - 2436
  • [35] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
    Reactions Weekly, 2018, 1701 (1) : 15 - 15
  • [36] AdalimumabDevelopment of anti-drug antibodies and no therapeutic response: case report
    Reactions Weekly, 2023, 1943 (1) : 21 - 21
  • [37] Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
    Sasson, S. C.
    Wilkins, L. E.
    Watson, R. A.
    Jolly, C.
    Brain, O.
    Klenerman, P.
    Olsson-Brown, A.
    Fairfax, B. P.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [38] The case for measuring anti-drug antibodies in people with multiple sclerosis
    Ryner, Malin Lundkvist
    Farrell, Rachel A.
    Fogdell-Hahn, Anna
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (06) : 697 - 699
  • [39] Anti-drug Antibodies Monitoring in Biologics Use: Clinical Implications
    Dhahri, Rim
    Athimni, Selma
    Slouma, Maroua
    Metoui, Leila
    Gharsallah, Imene
    Louzir, Bassem
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (03) : 235 - 238
  • [40] Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
    Kishimoto, Takashi Kei
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345